Sign in / Join Now
ETFs & Funds
Neurocrine Biosciences $
screen today. Small drug developer. Looks like a one-time revenue case, not certain though.
Add a reply...
Latest StockTalks »
people get NBIX breaking news and analysis by email alert.
Get email alerts on NBIX »
Neurocrine Biosciences, Inc.
Get latest price
From other sites
Neurocrine Biosciences Announces The Appointment Of David-Alexandre Gros M.D. President And Chief Operating Officer
at TheStreet (Jan 6, 2017)
Neurocrine Provides Update On FDA Advisory Committee For INGREZZA™ (valbenazine) For The Treatment Of Tardive Dyskinesia
at TheStreet (Jan 5, 2017)
Neurocrine Biosciences To Present At The 35th Annual J.P. Morgan Healthcare Conference
at TheStreet (Jan 3, 2017)
Neurocrine Biosciences Announces Chief Financial Officer Timothy P. Coughlin To Step Down
at TheStreet (Dec 21, 2016)
Neurocrine Biosciences To Present At The 2016 BMO Capital Markets Prescription For Success Healthcare Conference
at TheStreet (Dec 7, 2016)